United States · FDA National Drug Code directory
MEROPENEM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70594-076_3ee484ef-4e7f-464a-ac2e-7963d9dc5df6
- Product NDC
- 70594-076
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- MEROPENEM
- Labeler
- Xellia Pharmaceuticals USA LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210628
- Source listing expiry
- 20261231
Source-listed ingredients
- MEROPENEM — 1 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, GLASS in 1 CARTON (70594-076-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (70594-076-01) · 70594-076-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →